239 related articles for article (PubMed ID: 7705949)
1. Direct tumorigenic conversion of human gallbladder carcinoma cells by v-src but not by activated c-H-ras oncogene.
Tatsumoto T; Nakano S; Shimizu K; Ono M; Esaki T; Ohshima K; Niho Y
Int J Cancer; 1995 Apr; 61(2):206-13. PubMed ID: 7705949
[TBL] [Abstract][Full Text] [Related]
2. Src tyrosine kinase but not activated Ras augments sensitivity to taxanes through apoptosis in human adenocarcinoma cells.
Boudny V; Nakano S
Anticancer Res; 2003; 23(1A):7-12. PubMed ID: 12680188
[TBL] [Abstract][Full Text] [Related]
3. v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells.
Masumoto N; Nakano S; Fujishima H; Kohno K; Niho Y
Int J Cancer; 1999 Mar; 80(5):731-7. PubMed ID: 10048975
[TBL] [Abstract][Full Text] [Related]
4. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
Tokumitsu Y; Nakano S; Ueno H; Niho Y
J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha and -gamma inhibit the growth and neoplastic potential of v-src-transformed human epithelial cells by reducing Src tyrosine kinase activity.
Fujishima H; Nakano S; Tatsumoto T; Masumoto N; Niho Y
Int J Cancer; 1998 May; 76(3):423-9. PubMed ID: 9579582
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of anchorage-independent growth affect the growth of transformed cells on poly(2-hydroxyethyl methacrylate)-coated surfaces.
Fukazawa H; Nakano S; Mizuno S; Uehara Y
Int J Cancer; 1996 Sep; 67(6):876-82. PubMed ID: 8824562
[TBL] [Abstract][Full Text] [Related]
7. v-Src suppresses SHPS-1 expression via the Ras-MAP kinase pathway to promote the oncogenic growth of cells.
Machida K; Matsuda S; Yamaki K; Senga T; Thant AA; Kurata H; Miyazaki K; Hayashi K; Okuda T; Kitamura T; Hayakawa T; Hamaguchi M
Oncogene; 2000 Mar; 19(13):1710-8. PubMed ID: 10763828
[TBL] [Abstract][Full Text] [Related]
8. Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells.
Qin B; Ariyama H; Baba E; Tanaka R; Kusaba H; Harada M; Nakano S
Cancer Chemother Pharmacol; 2006 Nov; 58(5):577-84. PubMed ID: 16532343
[TBL] [Abstract][Full Text] [Related]
9. Src tyrosine kinase augments taxotere-induced apoptosis through enhanced expression and phosphorylation of Bcl-2.
Boudny V; Nakano S
Br J Cancer; 2002 Feb; 86(3):463-9. PubMed ID: 11875716
[TBL] [Abstract][Full Text] [Related]
10. Ornithine decarboxylase- and ras-induced cell transformations: reversal by protein tyrosine kinase inhibitors and role of pp130CAS.
Auvinen M; Paasinen-Sohns A; Hirai H; Andersson LC; Hölttä E
Mol Cell Biol; 1995 Dec; 15(12):6513-25. PubMed ID: 8524216
[TBL] [Abstract][Full Text] [Related]
11. Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases.
Uehara Y; Fukazawa H
Methods Enzymol; 1991; 201():370-9. PubMed ID: 1658554
[No Abstract] [Full Text] [Related]
12. Suppression of anoikis by v-Src but not by activated c-H-ras in human gallbladder epithelial cells.
Hisano C; Tanaka R; Fujishima H; Ariyama H; Tsuchiya T; Tatsumoto T; Mitsugi K; Nakamura M; Nakano S
Cell Biol Int; 2003; 27(5):415-21. PubMed ID: 12758089
[TBL] [Abstract][Full Text] [Related]
13. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
[TBL] [Abstract][Full Text] [Related]
14. Detection and cloning of potent transforming gene(s) from chewing tobacco-related human oral carcinomas.
Saranath D; Bhoite LT; Deo MG; Tandle AT; D'Costa J; Kolhapure RN; Govardhan MK; Banerjee K
Eur J Cancer B Oral Oncol; 1994 Jul; 30B(4):268-77. PubMed ID: 7950842
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of Jak-2 and Tyk-2 in a v-Src-transformed human gallbladder adenocarcinoma cell line.
Murakami Y; Nakano S; Niho Y; Hamasaki N; Izuhara K
J Cell Physiol; 1998 May; 175(2):220-8. PubMed ID: 9525481
[TBL] [Abstract][Full Text] [Related]
16. Labeling of v-Src and BCR-ABL tyrosine kinases with [14C]herbimycin A and its use in the elucidation of the kinase inactivation mechanism.
Fukazawa H; Uehara Y; Murakami Y; Mizuno S; Hamada M; Takeuchi T
FEBS Lett; 1994 Mar; 340(3):155-8. PubMed ID: 8131836
[TBL] [Abstract][Full Text] [Related]
17. v-sis oncogene-induced transformation of human fibroblasts into cells capable of forming benign tumors.
Yang D; Kohler SK; Maher VM; McCormick JJ
Carcinogenesis; 1994 Oct; 15(10):2167-75. PubMed ID: 7955050
[TBL] [Abstract][Full Text] [Related]
18. Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds.
Uehara Y; Fukazawa H; Murakami Y; Mizuno S
Biochem Biophys Res Commun; 1989 Sep; 163(2):803-9. PubMed ID: 2783121
[TBL] [Abstract][Full Text] [Related]
19. v-src transformation of rat embryo fibroblasts. Inefficient conversion to anchorage-independent growth involves heterogeneity of primary cultures.
Tavoloni N; Inoue H; Sabe H; Hanafusa H
J Cell Biol; 1994 Jul; 126(2):475-83. PubMed ID: 8034746
[TBL] [Abstract][Full Text] [Related]
20. Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts.
Matsuyoshi N; Hamaguchi M; Taniguchi S; Nagafuchi A; Tsukita S; Takeichi M
J Cell Biol; 1992 Aug; 118(3):703-14. PubMed ID: 1639852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
